Vanderbilt University Medical Center

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Vanderbilt University Medical Center sits in the top decile of US sponsors by registered trial count (#51 of 15,742 sponsors by registered trial count).

677 total trials 130 currently recruiting 400 completed early-phase tilt top decile by trial count

Vanderbilt University Medical Center: 677 sponsored US clinical trials, 130 recruiting.

Vanderbilt University Medical Center sponsors 677 registered US clinical trials on ClinicalTrials.gov, 130 of them currently recruiting, and 400 completed. 70 of these trials are in Phase 3-4 (later-stage) and 127 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Autonomic Failure, with 9 trials.

Top-decile sponsor footprint

Vanderbilt University Medical Center ranks in the top decile of sponsors by registered trial count (#51 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 54/100

400 of 467 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

677 total, page 10 of 14

TERMINATED NA

Lumen Apposing Metal Stents vs Lumen Apposing Metal Stent Plus Double Pigtail Stent for Endoscopic Drainage

NCT03049215

COMPLETED NA

Sleep Promotion to Improve Diabetes Management in Adolescents With T1D

NCT02786953

COMPLETED NA

Mitigating ACEs in Pediatric Primary Care: Cohort #2 With 6-24 Month Old Children

NCT04160013

COMPLETED

Cytokines and Genes in Therapeutic Response in Crohn's Disease

NCT03266471

TERMINATED NA

RESIPI for Reducing Perioperative Major Adverse Cardiac Events

NCT03208023

COMPLETED Phase 4

Trigger Finger Corticosteroid Injection With and Without Local Anesthetic

NCT04023695

COMPLETED NA

Protocolized Post-Extubation Respiratory Support Study

NCT03288311

TERMINATED NA

Trial Comparing Cosmetic Outcomes of Pediatric Laceration Closure Using Skin Glue, Medical Tape Versus Stitches

NCT03280628

TERMINATED Phase 4

Particulate Corticosteroid Versus Non-particulate Corticosteroid for Sacroiliac Joint Injection

NCT03166761

COMPLETED NA

Comparison of Standard Isolation With Targeted Isolation for Preventing Nosocomial Transmission of MRSA and VRE

NCT03268122

COMPLETED NA

Plant Based Diet, Ethnicity, and the Gut Microbiome

NCT03314194

TERMINATED NA

Visceral Manifold Study for the Repair of Thoracoabdominal Aortic Aneurysms

NCT03113383

COMPLETED NA

New Modalities for Detection of Oropharyngeal Cancer

NCT03226613

COMPLETED NA

A Mobile Health Intervention in Pulmonary Arterial Hypertension

NCT03069716

COMPLETED

The Impact of Diabetes on REvascularization

NCT03085524

COMPLETED Phase 2

Mitochondria and Chronic Kidney Disease

NCT03177798

COMPLETED

Human Immunome Program

NCT03118687

COMPLETED NA

Improving ACL Reconstruction Outcomes: CBPT

NCT03243162

COMPLETED NA

Discussing Death and Dying: An End of Life Curriculum to Empower Residents

NCT03186274

COMPLETED NA

Chronic Pain Skills Study - Vanderbilt University Medical Center

NCT03384953

COMPLETED

Gastrointestinal Symptoms in Postural Orthostatic Tachycardia Syndrome

NCT03263819

TERMINATED NA

Patient Satisfaction and Postoperative Analgesia Between Subarachnoid Block With 2-chloroprocaine Versus General Anesthesia for Knee Arthroscopy

NCT03173326

COMPLETED NA

Opioid Prescribing After Cesarean Delivery

NCT03168425

TERMINATED NA

Efficacy of a Mechanical Chair for Treatment of Benign Paroxysmal Positional Vertigo (BPPV)

NCT03161470

COMPLETED NA

Predictors of Response to Treatment for Depression

NCT03154008

COMPLETED NA

Comparison of Oxygenation and Ventilation With a Novel Nasal Mask Versus Standard of Care During Colonoscopy

NCT03139448

COMPLETED NA

Endotracheal Tube Securement Study

NCT03760510

COMPLETED NA

Competency-based Approaches to Community Health

NCT03141151

COMPLETED

Cholinesterase Activity and DeliriUm During Critical Illness Study

NCT03098472

COMPLETED NA

Calcium: Magnesium Balance, Microbiota, and Necroptosis and Inflammation

NCT04229992

COMPLETED NA

The Effects of a Music Therapist Designed Listening Program on Intraoperative Vitrectomy

NCT03147235

COMPLETED NA

Vanderbilt ICU Recovery Program Pilot Trial

NCT03124342

COMPLETED Phase 4

Cardiovascular Effects of GLP-1 Receptor Activation

NCT03101930

COMPLETED Phase 4

Norepinephrine-targeted Therapy for Action Control in Parkinson Disease

NCT03115827

COMPLETED NA

Comparison of Two-hand Mask Ventilation Technique: Standard V-E Versus Reversal V-E Technique

NCT03170037

COMPLETED NA

Preventing Hypoxemia With Manual Ventilation During Endotracheal Intubation (PreVent) Trial

NCT03026322

COMPLETED NA

A Randomized Controlled Trial to Deprescribe for Older Patients With Polypharmacy

NCT02979353

COMPLETED Phase 2

Fish Oil to Reduce Tobacco Use iN Expectant Mothers Study

NCT03077724

COMPLETED Phase 1

The Effect of Acute Lysine Administration on α-aminoadipic Acid (Sub-study)

NCT03063476

COMPLETED NA

Effect of Targeted Interventions to Improve Value Based Health Care for Inpatient Cardiology Patients

NCT03173157

COMPLETED NA

Discharge Follow-up Phone Call Program

NCT03050918

COMPLETED Phase 1

Pharmacogenomics of the Variability in the In Vivo Response to Glucocorticoids

NCT03023891

COMPLETED

Mechanisms of Weight Loss in Patients Diagnosed With Achalasia

NCT03063463

TERMINATED NA

Palliative Care for Non-Malignant Diseases (COMPASS Trial)

NCT03022630

COMPLETED NA

Mitigating ACEs in Pediatric Primary Care

NCT03058861

COMPLETED NA

Decision Support for Intraoperative Low Blood Pressure

NCT02726620

COMPLETED Phase 1

Diagnosing Natriuretic Peptide Deficiency

NCT03035929

COMPLETED Phase 1

CD36 in Nutrient Delivery and Its Dysfunction

NCT03012386

COMPLETED NA

Noradrenergic and Stress-Related Etiologies of Chronic Fatigue Syndrome

NCT03029377

COMPLETED

Assessment of Duodenal Epithelial Integrity in Celiac Disease With Mucosal Impedance

NCT03152279

← Previous Page 10 of 14 Next →

Phase Distribution

PhaseTrial count
Phase 1 65
Phase 2 62
Phase 3 14
Phase 4 56

What is open in the Vanderbilt University Medical Center pipeline

130 recruiting of 677 indexed (19% open); 400 completed (59%).

Phase mix: 70 late (III/IV) vs 127 early (I/II) (early-phase heavy).

Top condition: Autonomic Failure (9 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Vanderbilt University Medical Center: open-pipeline peers nationwide

Peers matched on 677 registered trials and 19% open enrollment, not the therapeutic-area sidebar.

Vanderbilt University Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 01,0002,0003,000 12%14%16%18%20%22%24% Total trials Recruiting share Vanderbilt University Medical CenterThe Cleveland ClinicUniversity of California, DavisWeill Medical College of Cornell UniversityIcahn School of Medicine at Mount SinaiCalifornia Polytechnic State University-San Luis ObispoPhoenix Children's HospitalMayo ClinicUniversity of South Carolina
Vanderbilt University Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Vanderbilt University Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 677 trials (± recruiting share)

Sponsors near 19% open enrollment (± trial volume)

What to do with this Vanderbilt University Medical Center page

677 registered trials is a research-attention snapshot, not an endorsement of Vanderbilt University Medical Center or any single study.

  • 130 of Vanderbilt University Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Autonomic Failure is the condition Vanderbilt University Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Autonomic Failure trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Vanderbilt University Medical Center pipeline card: 677 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.